Dysregulated mTOR signaling is tightly associated with the development of several hyperproliferative skin disorders, including skin cancer, and inflammatory skin diseases (Buerger et al., 2013; Mossmann et al., 2018; Varshney and Saini, 2018; Deng et al., 2021). The gene discussed is MTOR; the disease is inflammatory skin disease.